&nbsp;

Feb 2024

Drug

pamidronate

Quick Link(s):

Feb 2024

Regimen

NELA

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Drugs Used:

nelarabine (Unfunded)

Quick Link(s):

Regimen Monograph

Feb 2024

Regimen

DEXAPOMA+ISAT

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

New Drug Funding Program

Isatuximab - In Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Exceptional Access Program

pomalidomide - In combination with isatuximab and dexamethasone for relapsed or refractory multiple myeloma, according to specific criteria

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2024

Regimen

CARFDEXA+ISAT; CARFDEXA(W)+ISAT

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

New Drug Funding Program

Isatuximab and Carfilzomib - In Combination with Dexamethasone for Relapsed or Refractory Multiple Myeloma

New Drug Funding Program

Isatuximab and Carfilzomib - In Combination with Dexamethasone for Relapsed or Refractory Multiple Myeloma

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2024

Drug

olaparib

Other Name(s): Lynparza®

Quick Link(s):

Jan 2025

Regimen

CAPIFLVS

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

fulvestrant

Drugs Used:

capivasertib (Unfunded),

fulvestrant

Quick Link(s):

Regimen Monograph

Jan 2025

Regimen

ENFO

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Palliative

Funding:

New Drug Funding Program

Enfortumab Vedotin - Previously Treated Advanced or Metastatic Urothelial Cancer

Drugs Used:

enfortumab vedotin

Quick Link(s):

Regimen Monograph

Jan 2025

Drug

carfilzomib

Other Name(s): Kyprolis®

Quick Link(s):

Feb 2024

Regimen

CRBPPEME+AMIV

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin,

amivantamab (Unfunded)